News & Events

News October 19, 2026

BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group

Partnership with Established Southern California Behavioral Health Provider Aims to Accelerate Innovative...

News October 13, 2026

BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives

BURLINGTON, Mass. and JERUSALEM, October 13, 2026 — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

News August 12, 2026

BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights

Record second quarter 2026 revenue increased 35% to $17.1 million, compared with Q2 2025 Adjusted EBITDA...

Events November 9 - November 11, 2026

Cologne, Germany

BIO-EUROPE 2026

BrainsWay will be participating in BIO-Europe 2026, taking place on November 9–11, 2026, in Cologne,...

Events October 15 - October 17, 2026

Naples, Italy

7TH EUROPEAN CONFERENCE ON BRAIN STIMULATION IN MENTAL HEALTH

BrainsWay will be participating in the 7th European Conference on Brain Stimulation in Mental Health,...

Events, News September 30 - September 30, 2026

Rotterdam, The Netherlands

ISAM Global Addiction Therapeutics Innovation Day (GATID) 2026

BrainsWay will be participating in the ISAM Global Addiction Therapeutics Innovation Day (GATID), taking...

In the media July 9, 2026

Lifestyle 5 of America’s greatest medical breakthroughs revealed as the nation marks 250 years

For most of America’s 250 years, mental illness was largely treated indirectly with medication, or...

In the media July 1, 2026

BrainsWay Featured in USA Today: America250

BrainsWay was featured in USA Today for its leadership in advancing Deep TMS™, a noninvasive treatment...

In the media November 24, 2025

FDA grants 510(k) clearance for TMS as adjunctive for major depressive disorder in young people

Key takeaways: BrainsWay Deep TMS is cleared for use by adolescents and adults with major depressive...